06/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

06/2024

Jun 13, 2024, 10:25 | Blog
Concluding the "Equity, Diversity, and Inclusion (EDI) Principles in Cancer Care" event - SIOP Europe
SIOP Europe shared a post on LinkedIn:    . “Concluding the "Equity, Diversity, and Inclusion (EDI) Principles…
Jun 13, 2024, 09:56 | Blog
Advocacy in action - Levine Cancer
Levine Cancer shared a post on X/Twitter: ''Advocacy in action! The House of Delegates for…
Jun 13, 2024, 09:51 | Blog
Yelak Biru: Francesca Gay Wins Brian G.M. Durie Outstanding Achievement Awarde!
Yelak Biru, President and CEO of the International Myeloma Foundation, shared on X: . “Congratulations to Dr.…
Jun 13, 2024, 09:46 | Blog
Patrick Hwu: It was a beautiful representation of why we all got into this field
Patrick Hwu shared on X: “Last week at ASCO24, there was a storyboard wall where…
Jun 13, 2024, 09:39 | Blog
Aparna Kesarwala has been named a 2024 Gilead Research Scholar - Winship Cancer Institute of Emory University
Winship Cancer Institute of Emory University announced on X:    . “Winship researcher Aparna Kesarwala,…
Jun 13, 2024, 09:34 | Blog
Submit an abstract for the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
American Association for Cancer Research shared a post on LinkedIn: “Submit an abstract by June 26…
Jun 13, 2024, 09:16 | Blog
An online course on registration of Childhood Cancer - IARC
IARC – International Agency for Research on Cancer / World Health Organization shared on their LinkedIn:…
Jun 13, 2024, 09:00 | Insight
Key Advances in Targeted Radiotherapies at SNMMI24 by Actinium
Actinium Pharmaceuticals presented compelling data from their diverse clinical trials at SNMMI24: Key among these…
Jun 13, 2024, 08:34 | Cancer Types
Parathyroid Cancer: What patients should know about
What is Parathyroid Cancer? Parathyroid cancer is a rare endocrine malignancy that originates in the…
Jun 13, 2024, 07:54 | Blog
Connect to the ESMO Virtual Plenary to stay up to date with the latest in immunotherapy
ESMO shared on LinkedIn: "What are the early safety and activity profiles of a first-in-class PD-1/IL-2…
All: 2740 Posts: 1611 - 1620
Special Coverage